Researchers believe interacting with other people who are also having treatment reduces stress levels, leading to better survival prospects
Socialising with others who also have cancer, could potentially improve survival prospects, according to new research.
Patients undergoing chemotherapy who socialise with other sufferers have a 68% risk of dying within five years, scientists from the National Human Genome Research Institute have found.
This is compared to a 69.5% risk if patients are isolated from other sufferers during their treatment, the research adds.
Lead author Jeff Lienert, said: “A two percent difference in survival might not sound like a lot, but it’s pretty substantial. If you saw 5,000 patients in nine years, that two percent improvement would affect 100 people.”
A student in Africa has reportedly discovered an alternative treatment for an aggressive type of breast cancer.
Sandra Musujusu, who studies at the University of Science and Technology in Abuja, Nigeria, is developing an alternative treatment for a subtype of breast cancer commonly found in black women. The Sierra Leone native’s research was unveiled earlier this month when World Bank director Jaime Saavedra Chanduvi visited the West African university as a part of his assessment tour of the 10 African Centers of Excellence locations, funded to encourage research to benefit African countries facing problems.
Ovarian cancer deaths have fallen around the world, largely because of the widespread use of the contraceptive pill, according to a major new study.
A study by Italian researchers has found that the number of people dying from ovarian cancer has dropped over the past decade due to increased use of the contraceptive pill together with a decline in the long-term use of hormone replacement therapy (HRT).
New drug discovered by team including Nobel Prize-winning chemist shows ‘promise’ as a replacement for opium-based drugs like morphine
Scientists believe they may have found a new form of painkiller that works just as well as morphine but lacks its potentially lethal side effect and is not addictive.
A team that included Nobel Prize-winning chemist Professor Brian Kobilka, of Stanford University in the US have discovered a new compound that not only seems to be more effective than morphine in controlling pain, but also has fewer side effects too.
Cancer patients suffering from pain not controlled with the usual painkillers such as paracetamol and codeine may be prescribed morphine. Whilst this is a very effective drug it can also cause severe constipation, nausea and in extreme cases, if too much is taken, it can affect the brain’s breathing centre.
Hormone replacement therapy can triple the risk of breast cancer, the biggest ever study has found, following more than a decade of controversy.
Hormone replacement therapy (HRT) helps minimise the more troublesome symptoms of menopause such as hot flushes, disrupted sleep, migraines, mood changes and depression. That is why the National Institute of Health and Care Excellence (NICE), changed guidance to encourage more doctors to prescribe HRT claiming too many menopausal women had been left suffering in silence.
But doctors were reluctant to prescribe it after a study in 2002 suggested it could raise the risk of cancer, a claim later widely disputed. However, new findings by the Institute of Cancer Research and Breast Cancer Now suggest that these concerns were justified.
When Karen Koehler was diagnosed with chronic lymphocytic leukemia in 2011, she was told not to worry. She had a mild case that could simply be monitored, her doctor said. But two years later, the cancer took a turn for the worse when a genetic mutation made it aggressive and difficult to treat with chemotherapy. “I was told I had 10 months to live,” said Koehler, 59, a retired teacher who lives in Park Ridge, New Jersey. At best, she was told, chemo might stretch that to two years.
Then Koehler was accepted into a clinical trial at Memorial Sloan Kettering Cancer Center in New York that aimed to turn her own immune cells into cancer killers. Within a month of treatment, her leukemia had vanished. “There were no cancer cells whatsoever,” said Koehler, who remains cancer-free today.
Women could be tested for ovarian cancer in a similar way as doctors test for cervical cancer
Ovarian cancer could be detected years before any symptoms emerge after scientists at Oxford University found a way to spot the first signs of the disease.
A study funded by Ovarian Cancer Action has discovered a protein that brings us closer to early detection and better treatment of Ovarian cancer. The discovery of the protein, SOX2, means that the disease could be spotted years before symptoms arise, giving women a better chance of successful treatment.